ClinicalTrials.gg
CompletedNCT06653868Updated Oct 21, 2026

Grafting of the Peri-implant Bony Defects Around Immediate Implants Using Xenogenic Versus Alloplastic Sticky Grafts

An interventional study of Immediate dental implant with filling the peri implant gap with xenogenic sticky bone in Bone Loss, Alveolar, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 21, 2026Now CompletedPrimary completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Alveolar Bone Loss by Cairo University — 10 open to participants now, 11 under way, none of them phase 3. Alveolar Bone Loss · Cairo University.

Enrollment
11th of 30
20 · median 20
Started
2024
with 5 others
No phase
29 of 30
10 open now
Registered
24th of 30
by date

Among the 30 studies in Alveolar Bone Loss by Cairo University, this one is the 11th largest by enrollment, is one of 6 that started in 2024, is one of 29 with no phase, and was the 24th registered.

Alveolar Bone Loss

320 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.

Browse Alveolar Bone Loss studies →

Open to participants now

10 of the 30 studies in Alveolar Bone Loss by Cairo University are open now, in 1 country. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.

This study: 20 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Alveolar Bone Loss by Cairo University, or all of them as a file.
02

Study summary

In patients with a single non restorable tooth, does filling the peri-implant buccal gap with alloplastic sticky grafts result comparable results compared to xenogenic sticky grafts?

Read the detailed description

The buccal aspect of the dental implant has great importance, especially in the aesthetic zone, because the buccal bone is very thin especially in the anterior maxilla and its resorption can result in recession of the soft tissue. A gap occurs in immediately placed implant due to discrepancy between the dimensions of the extraction socket and the implant. Augmentation of the buccal gap decreases the amount of buccal bone resorption and soft tissue recession . Filling the peri-implant defects has been widely discussed to prevent further bone loss. The use of biologic materials such as platelet rich fibrin can enhance the quality of alloplastic bone grafts to give comparable effect when compared to xenogenic grafts.

03

Conditions studied

  • Bone Loss, Alveolar

Browse trials for

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients with healthy systemic condition (Mazzotti et al., 2023).
  2. Age from 20-50 years old
  3. Patients must be free of any systemic disease which could influence the surgical procedure.
  4. Tooth involved in the esthetic zone.
  5. Sufficient hard and soft tissue volume in vertical and buccolingual direction
  6. Natural teeth adjacent to the involved tooth will be required to be free from infection.
  7. Controlled oral hygiene.
  8. Indication for tooth extraction included (Degidi et al., 2012);

    • Endodontic failures
    • Untreatable caries
    • Non- restorable teeth
    • Vertical root fracture
    • Remaining roots

Exclusion criteria

Exclusion Criteria:

- 1.Pregnant females 2.Smokers (Khuller, 2009) 3.Unmotivated and uncooperative patients with poor oral hygiene 4.Patients with habits that may compromise the longevity and affect the result of the study as alcoholism or parafunctional habits.

5.Presence of acute dento-alveolar infection.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    immediate implant placement surgery with filling the gap distance with alloplastic sticky graft

    immediate implant placement surgery with filling the gap distance with injectable platelet rich fibrin combined with alloplast.

    Procedure: Immediate dental implant with filling the peri implant gap with xenogenic sticky bone

  • Experimental
    immediate implant placement surgery with filling the gap distance with xenogenic sticky bone

    immediate implant placement surgery with filling the gap distance with injectable platelet rich fibrin combined with xenograft.

    Procedure: Immediate dental implant with filling the peri implant gap with xenogenic sticky bone

Interventions

  • ProcedureImmediate dental implant with filling the peri implant gap with xenogenic sticky bone

    gap distance augmentation with bone graft

    Also known as: gap distance augmentation

06

What researchers measure

Primary outcomes

  1. bone changes

    superimposition

    Time frame: 6 months

Secondary outcomes

  1. pink esthetic score (0-14)

    soft tissue esthetics

    Time frame: 6 months

07

Study locations

1 site
  • Cairo University
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Feb 2026, 16 months.

Of 169 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 16 months is below that.

Counting every sponsor, half of 169 studies reached it within 18 months; a quarter within 11 and three quarters within 30.

Primary completion moved once since we started tracking on Sep 25, 2026: Mar 2026 → Feb 2026, on Oct 21, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2024
First posted
Oct 22, 2024
StartActual
Oct 20, 2024
Primary completionActual
Feb 20, 2026was Mar 2026
CompletionActual
Mar 15, 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 21, 2026
Sites
1 site removed
Show 1 removed
  • Cairo University · Cairo, Egypt
Oct 21, 2026
Primary completion
Mar 20, 2026→Feb 20, 2026 (actual)
Oct 21, 2026
Study completion
Mar 20, 2026→Mar 15, 2026 (actual)
Oct 21, 2026
Interventions
Changed dental implant with bone augmentation→Immediate dental implant with filling the peri implant gap with xenogenic sticky bone
Oct 21, 2026
Secondary outcomes
1 edited
What changed in the outcomes
  • Editedpink esthetic score (0-14)Time frame: 6 months
Oct 21, 2026
Title
Grafting of the Peri-implant Bony Defects Around Immediate Implants Using Xenogenic Versus Alloplastic Sticky Grafts: Randomized Controlled Clinical Trial
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Recruiting→Completed
    1 site removed
    Show 1 removed
    • Cairo University · Cairo, Egypt
    Primary completion Mar 20, 2026→Feb 20, 2026 (now actual)
    Study completion Mar 20, 2026→Mar 15, 2026 (now actual)
    Secondary outcomes 1 edited
    What changed in the outcomes
    • Editedpink esthetic score (0-14)Time frame: 6 months
    Interventions Changed dental implant with bone augmentation→Immediate dental implant with filling the peri implant gap with xenogenic sticky bone
    Title Grafting of the Peri-implant Bony Defects Around Immediate Implants Using Xenogenic Versus Alloplastic Sticky Grafts: Randomized Controlled Clinical Trial
    + 5 other changes: verification date, oversight details, criteria formatting, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06653868
Lead sponsor
Cairo University
Responsible party
bassant mohye (bassant mohye, Cairo University) — Principal investigator
First posted
Oct 22, 2024
Start date
Oct 20, 2024
Primary completion
Feb 20, 2026
Completion
Mar 15, 2026
Last update
Oct 21, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion